Roxithromycin molecular structure

Roxithromycin

Also known as: Rulide, Roxid, Surlid, Roxo, Biaxsig

CAS Number: 80214-83-1

Macrolide Antibacterial

Pharmacopeia Standards

EPBPIPJPCP

Mechanism of Action

Roxithromycin binds reversibly to the 23S rRNA of the bacterial 50S ribosomal subunit, blocking the peptide exit tunnel and arresting translocation of peptidyl-tRNA. Protein synthesis stalls, producing a bacteriostatic effect against most susceptible Gram-positive cocci and atypical respiratory pathogens. The 9-[O-(2-methoxyethoxy)methyl]oxime side chain confers markedly greater acid stability than erythromycin base.

Technical Specifications

Generic / INN NameRoxithromycin
CAS Registry Number80214-83-1
Molecular FormulaC41H76N2O15
Molecular Weight837.05 g/mol g/mol
Typical Purity98.0-102.0% on the anhydrous basis (EP/BP); single unspecified impurity NMT 0.5%, total impurities NMT 3.0%
Storage ConditionsStore in tightly closed HDPE drums with double LDPE liner, protected from light and moisture, below 25 degrees C
Shelf Life48 months from date of manufacture when stored per label conditions
CategoryMacrolides

Specifications are indicative and intended for sourcing reference only. Always confirm against the supplier's Certificate of Analysis and the applicable pharmacopeial monograph before issuing a purchase specification.

Typical Applications

Oral solid dosage forms (film-coated tablets, dispersible paediatric tablets, dry syrup for reconstitution) and fixed-dose combinations with ambroxol or bromhexine that are common in Indian and Southeast Asian respiratory portfolios.

Manufacturers (0+)

View all →
No manufacturers listed yet. Register your company to appear here.